Viewing Study NCT03038256


Ignite Creation Date: 2025-12-24 @ 11:20 PM
Ignite Modification Date: 2026-01-04 @ 7:57 AM
Study NCT ID: NCT03038256
Status: UNKNOWN
Last Update Posted: 2023-03-22
First Post: 2017-01-25
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Effect of Concurrent Capecitabine-based Long-term Radiotherapy Followed by XELOX Plus TME in Patients With High Risk Rectal Cancer: a Multi-centers, Randomized Controlled, Open-Label Trial
Sponsor: Peking University People's Hospital
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2018-01-31
Start Date Type: ACTUAL
Primary Completion Date: 2023-04-01
Primary Completion Date Type: ESTIMATED
Completion Date: 2025-06-01
Completion Date Type: ESTIMATED
First Submit Date: 2017-01-25
First Submit QC Date: None
Study First Post Date: 2017-01-31
Study First Post Date Type: ESTIMATED
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: None
Results First Post Date Type: None
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2023-03-19
Last Update Post Date: 2023-03-22
Last Update Post Date Type: ACTUAL